vimarsana.com
Home
Live Updates
Apexigen Announces Phase 2 Data Evaluating Sotigalimab, its : vimarsana.com
Apexigen Announces Phase 2 Data Evaluating Sotigalimab, its
- Marked increases in overall survival observed across soft tissue sarcoma patients - - Demonstrated improvement of median progression free survival in...
Related Keywords
Chicago ,
Illinois ,
United States ,
William Duke ,
Xiaodong Yang ,
Bruce Mackle ,
Apexigen Inc ,
Columbia University ,
Securities Exchange ,
Nasdaq ,
Chief Executive Officer ,
Securities Act ,
Securities Exchange Act ,
Nasdaq Apgn ,
Apexigen ,
vimarsana.com © 2020. All Rights Reserved.